160 related articles for article (PubMed ID: 34597971)
1. Choroidal metastasis as initial presentation of aggressive medullary thyroid carcinoma with widespread mediastinal, brain, pituitary, bone, lung, and liver metastasis: Case report and literature review.
Al Hassan MS; El Ansari W; Alater A; Darweesh A; Abdelaal A
Int J Surg Case Rep; 2021 Oct; 87():106419. PubMed ID: 34597971
[TBL] [Abstract][Full Text] [Related]
2. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
3. Brain metastasis from calcitonin-negative medullary thyroid carcinoma.
Baptista PF; Fonseca LCM; Carvalho AFC; Silva SNVD; Freitas CRO
Ann Endocrinol (Paris); 2022 Aug; 83(4):258-260. PubMed ID: 35537523
[TBL] [Abstract][Full Text] [Related]
4. Medullary Thyroid Cancer - Feature Review and Update on Systemic Treatment.
Dabelić N; Jukić T; Fröbe A
Acta Clin Croat; 2020 Jun; 59(Suppl 1):50-59. PubMed ID: 34219884
[TBL] [Abstract][Full Text] [Related]
5. Multiple Endocrine Neoplasia Type 2B Associated Mixed Medullary and Follicular Thyroid Carcinoma in A Chinese Patient with RET M918T Germline Mutation.
Qi XP; Lin GB; Chen B; Li F; Cao ZL; Zheng WH; Zhao JQ
Endocr Metab Immune Disord Drug Targets; 2021; 21(3):554-560. PubMed ID: 32660411
[TBL] [Abstract][Full Text] [Related]
6. [Clinical diagnosis and treatment of familial medullary thyroid carcinoma caused by a p.C618Y RET proto-oncogene mutation in a Chinese pedigree].
Zhao JQ; Guo L; Qi XP; Chen ZG; Wang KJ; Lou JL; Yu XH; Cheng J; Jin HY; Li XL; Ying RB; Zhang XN
Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(6):440-4. PubMed ID: 23660264
[TBL] [Abstract][Full Text] [Related]
7. RET Proto-oncogene Gene Mutation Is Related to Cervical Lymph Node Metastasis in Medullary Thyroid Carcinoma.
Wang S; Wang B; Xie C; Ye D
Endocr Pathol; 2019 Dec; 30(4):297-304. PubMed ID: 31494787
[TBL] [Abstract][Full Text] [Related]
8. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic dilemma in a patient with history of medullary thyroid carcinoma and abnormal serum liver enzymes; a case report with six years follow up.
Rahmani F; Tohidi M; Azmoudeh-Ardalan F; Sadeghi A; Hadaegh F
BMC Endocr Disord; 2023 Aug; 23(1):186. PubMed ID: 37649029
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis, treatment, and follow-up of medullary thyroid carcinoma: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism.
Maia AL; Siqueira DR; Kulcsar MA; Tincani AJ; Mazeto GM; Maciel LM
Arq Bras Endocrinol Metabol; 2014 Oct; 58(7):667-700. PubMed ID: 25372577
[TBL] [Abstract][Full Text] [Related]
11. Axillary Lymph Node Metastasis in Medullary Thyroid Carcinoma: A Case Report.
Rasihashemi SZ; Azhough R; Ramouz A
Iran J Otorhinolaryngol; 2017 Sep; 29(94):295-297. PubMed ID: 28955678
[TBL] [Abstract][Full Text] [Related]
12. Pediatric Medullary Thyroid Carcinoma.
Starenki D; Park JI
J Pediatr Oncol; 2015; 3(2):29-37. PubMed ID: 27014708
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and Clinical Presentation of Medullary Thyroid Carcinoma.
Raue F; Frank-Raue K
Recent Results Cancer Res; 2015; 204():61-90. PubMed ID: 26494384
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Follow-up in Medullary Thyroid Carcinoma.
Raue F; Frank-Raue K
Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391
[TBL] [Abstract][Full Text] [Related]
15. Optic disc and choroidal metastasis from sporadic medullary thyroid carcinoma: case report and review of the literature.
Yildiz I; Sen F; Tuncer S; Kilic L; Basaran M; Bavbek S
Onkologie; 2011; 34(11):630-3. PubMed ID: 22104161
[TBL] [Abstract][Full Text] [Related]
16. Anti-carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma: are carcinoembryonic antigen and somatostatin receptor expression prognostic factors?
Behr TM; Gratz S; Markus PM; Dunn RM; Hüfner M; Schauer A; Fischer M; Munz DL; Becker H; Becker W
Cancer; 1997 Dec; 80(12 Suppl):2436-57. PubMed ID: 9406695
[TBL] [Abstract][Full Text] [Related]
17. F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients.
Terroir M; Caramella C; Borget I; Bidault S; Dromain C; El Farsaoui K; Deandreis D; Grimaldi S; Lumbroso J; Berdelou A; Hadoux J; Hescot S; Hartl D; Baudin E; Schlumberger M; Leboulleux S
Thyroid; 2019 Oct; 29(10):1457-1464. PubMed ID: 31530235
[No Abstract] [Full Text] [Related]
18. Selpercatinib for treating recurrent mixed medullary and follicular cell-derived thyroid carcinoma: a case report.
Kadoya M; Suganuma N; Matsubara Y; Takase H; Kumagai E; Toda S; Yamazaki H; Masudo K; Fujii S; Saito A
Surg Case Rep; 2024 Apr; 10(1):92. PubMed ID: 38647958
[TBL] [Abstract][Full Text] [Related]
19. Rare presentation of occult medullary carcinoma of the thyroid as a mediastinal mass.
Daraki V; Koukouraki S; Velegrakis G; Mamalaki E; Haniotis VT; Kalikakis G; Stathaki MI; Karkavitsas N; Papavasiliou SS
Hormones (Athens); 2012; 11(2):210-4. PubMed ID: 22801569
[TBL] [Abstract][Full Text] [Related]
20. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.
Scollo C; Baudin E; Travagli JP; Caillou B; Bellon N; Leboulleux S; Schlumberger M
J Clin Endocrinol Metab; 2003 May; 88(5):2070-5. PubMed ID: 12727956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]